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ABSTRACT
The formability and potential of zinc pectinate nanoparticles as an oral insulin carrier 
were investigated. Zinc pectinate nanoparticles were prepared through ionotropic 
gelation of pectin with zinc ions. When required, sodium chloride was added as 
channeling agent to induce rapid insulin release from nanomatrices. The formed 
nanoparticles were subjected to in vitro size, morphology, zeta potential, drug content, 
drug association efficiency, drug release, drug-polymer and polymer-polymer 
interaction studies by means of zetasizer, scanning electron microscope, high 
performance liquid chromatography, dissolution tester, differential scanning 
calorimeter and fourier transform infra-red spectrometer, as well as in vivo blood 
glucose lowering investigation using streptozotocin-induced diabetic rats. Pectin- 
insulin solution at pH 3 was ideal for use in nanoparticle preparation with Zn2+ as 
crosslinking agent. The formed nanoparticles were able to encapsulate insulin 
substantially due to favourable electrostatic interaction between negatively charged 
pectin molecules with insulin and Zn2+. Unexpectedly, deionized water was found to 
exhibit a higher blood glucose lowering capacity than insulin solution, and to a lesser 
extent, blank and insulin loaded zinc pectinate nanoparticles. This was primarily due 
to interaction between water with insulin and/or excipients can lead to reduced water 
migration from gastrointestinal tract to systemic circulation. Formulation of insulin 
into polymeric nanoparticles may introduce complications in therapeutics related to 
water-nanoparticles interaction.
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